Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Oct 09, 2022 12:43pm
313 Views
Post# 35014851

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The 2nd PP

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The 2nd PP

Infinity ... 

1) Strenghtening ownership is key to a better negotiating position

Until we know who participates in this 2nd pp, your comment on "friends and family" is all air to me.  

You are probably aware though that TLT can be bought over for peanuts if they don't have solid financial partners assuming an hostile takeover.  So management has the responsibility to take the appropriate steps that will put them in the best position if you want TLT to be in the best position to negociate a deal for the shareholders.  

You had opportunities to participate in past pp.  Have you jumped on the opportunity?

I won't complain if TLT is building a larger base of credible long investors that could help us maximize shareholder values when ngociations come.

2)  Transforming an industry 

I don't think TLT management have been over paid, when compared to big pharmas executives that have a safety net, that are not trailblazing, that have no personal risk.  


TLT has been working on this disruptive technology for more than 20y, without any guarantee, months after months. They ran into lots of issues and obstacles that could have ended this adventure and that would have jeopardized your own investment.  They fought hard to find solutions, be creative, etc ...  So you take for granted a lot of things for granted in your comments.  Especially that you might one day be a medical benefiaciary of that new technology!  How much do you think it's worth for your own life?

 

<< Previous
Bullboard Posts
Next >>